| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |